Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-16

Clinical Trial Update: Safety and Tolerability of Glyceryl Tribenzoate (GTB) Capsules in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability study of Glyceryl Tribenzoate (GTB) capsules in healthy subjects, with the neurological disorder listed as the condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glyceryl Tribenzoate (GTB) Capsules (Glyceryl Tribenzoate)

Snippet

Sponsor: Forest Hills Lab | Conditions: Neurological Disorder | Phase 1 | Status: COMPLETED